Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progression Free Survival of the Treatment”

84 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 84 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03164616
What this trial is testing

Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).

Who this might be right for
Non Small Cell Lung Cancer NSCLC
AstraZeneca 1,186
Large-scale testing (Phase 3)UnknownNCT04764487
What this trial is testing

A Web-mediated Follow-up With the Web-application KidneyPRO Versus Standard Follow-up for Patients With Advanced Renal Cell Carcinoma Treated With Axitinib/Pembrolizumab in First Line

Who this might be right for
Renal Cell Carcinoma Metastatic
Weprom 178
Not applicableStudy completedNCT02575560
What this trial is testing

Weekly Use First-generation EGFR-TKI in the Treatment of EGFR-TKI Acquired Resistance Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
EGFR-TKI Resistant Mutation
Qingdao Central Hospital 30
Not applicableLooking for participantsNCT05299840
What this trial is testing

Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Oncomedics 450
Not applicableLooking for participantsNCT05749627
What this trial is testing

Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
The First Affiliated Hospital of Nanchang University 20
Large-scale testing (Phase 3)Study completedNCT00929240
What this trial is testing

Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 287
Not applicableActive Not RecruitingNCT07233759
What this trial is testing

The Study Collect Clinical Data From the Treatment of Liver Cancer With New Drugs After 2019 and Integrate Biochemical and Pathological Indicators to Analyze Prognostic Outcomes, Including Overall Survival, Progression-free Survival, and Complications.

Who this might be right for
Liver CancerPembrolizumabAtezolizumab+1 more
National Taiwan University Hospital 2,500
Not applicableStudy completedNCT02385604
What this trial is testing

The Predictive Value of CT-PET in Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
St. James's Hospital, Ireland 250
Not applicableLooking for participantsNCT06283927
What this trial is testing

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioblastoma, IDH-wildtype+5 more
Jasper Gerritsen 464
Testing effectiveness (Phase 2)Looking for participantsNCT06384560
What this trial is testing

Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)

Who this might be right for
Localized Pancreatic AdenocarcinomaBorderline Resectable Pancreatic AdenocarcinomaResectable Pancreatic Adenocarcinoma
Amsterdam UMC, location VUmc 66
Not applicableStudy completedNCT00897533
What this trial is testing

Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
ECOG-ACRIN Cancer Research Group 137
Large-scale testing (Phase 3)Study completedNCT00642577
What this trial is testing

Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 214
Testing effectiveness (Phase 2)WithdrawnNCT01174537
What this trial is testing

New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma

Who this might be right for
GlioblastomaSarcomaNeuroblastoma
Hadassah Medical Organization
Large-scale testing (Phase 3)UnknownNCT00764166
What this trial is testing

A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel

Who this might be right for
Adenocarcinoma of the Prostate
Assistance Publique - Hôpitaux de Paris 254
Not applicableEnded earlyNCT01277133
What this trial is testing

An Observational Study on The Correlation Between Time of Initiation of Avastin (Bevacizumab) Treatment And Progression-Free Survival in Patients With Metastatic Breast Cancer (CRONOS 2)

Who this might be right for
Breast Cancer
Hoffmann-La Roche 83
Testing effectiveness (Phase 2)UnknownNCT04029428
What this trial is testing

Peptide Receptor Radionuclide Therapy in the Treatment of Advanced, Non-resectable and/or Symptomatic Tumors With SSTR Overexpression

Who this might be right for
Neuroendocrine Tumors
University of Warmia and Mazury 150
Large-scale testing (Phase 3)Looking for participantsNCT06520345
What this trial is testing

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 430
Testing effectiveness (Phase 2)Study completedNCT00118755
What this trial is testing

Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 435
Testing effectiveness (Phase 2)Looking for participantsNCT07212933
What this trial is testing

The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial

Who this might be right for
Gastric (Stomach) CancerBiological TherapyImmunotherapy
Chinese PLA General Hospital 90
Large-scale testing (Phase 3)Study completedNCT00678535
What this trial is testing

Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer

Who this might be right for
Gastric Cancer
Merck KGaA, Darmstadt, Germany 904
Load More Results